Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 3Oligodendroglioma 2Glioma 2Glioblastoma 2Brain Neoplasms 2Astrocytoma 2Advanced Malignant Solid Tumor 2Rhabdoid Tumor 1Resectable Pancreatic Cancer 1Resectable Esophageal Cancer 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Neoplasms 1Multiple Myeloma 1Melanoma 1Medulloblastoma 1Locally Advanced Pancreatic Adenocarcinoma 1Leukemia, Plasma Cell 1Gliosarcoma 1Fallopian Tube Neoplasms 1Diffuse Intrinsic Pontine Glioma 1Carcinoma, Ovarian Epithelial 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Ductal, Breast 1Adult Solid Neoplasm 1Adenoma, Islet Cell 1

Interventions

Granulocyte-Macrophage Colony-Stimulating Factor 1Colony-Stimulating Factors 1Adjuvants, Immunologic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Resectable Pancreatic Cancer × Colony-Stimulating Factors × Clear all
NCT04810910 2021-11-16

Personalized Neoantigen Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy

Zhejiang Provincial People's Hospital

Phase 1 Unknown
20 enrolled
Gastrointestinal

Resectable Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡